# Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/perceptions-and-lived-experiences-with-abemaciclib-and-endocrine-therapy-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Helena Harder,Val Jenkins,Lesley Fallowfield |
| Citations | 0 |
| DOI | 10.1080/14796694.2026.2672132 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pmc.ncbi.nlm.nih.gov/articles/PMC13228952/ |
| OpenAlex ID | https://openalex.org/W7162123128 |
| PMID | 42169666 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Helena Harder](https://scholariq.org/researchers/helena-harder/)
- [Val Jenkins](https://scholariq.org/researchers/val-jenkins/)
- [Lesley Fallowfield](https://scholariq.org/researchers/lesley-fallowfield/)

## Paper funders

- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)

## Paper journal

- [Future Oncology](https://scholariq.org/journals/future-oncology/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.